2007
DOI: 10.2174/138620707782507340
|View full text |Cite
|
Sign up to set email alerts
|

Yeast Genomics and Drug Target Identification

Abstract: The budding yeast Saccharomyces cerevisiae is well recognized as a preferred eukaryote for the development of genomic technologies and approaches. Accordingly, a sizeable complement of genomic resources has been developed in yeast, and this genomic foundation is now informing a wide variety of disciplines. In particular, yeast genomic methodologies are gaining an expanding foothold in drug development studies, most notably as a preliminary tool towards drug target identification. In this review, we highlight m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
6
3
1

Relationship

1
9

Authors

Journals

citations
Cited by 28 publications
(16 citation statements)
references
References 62 publications
0
16
0
Order By: Relevance
“…Yeast cells are useful in the identification of genes important in drug toxicity (Bharucha & Kumar, 2007). An advantage of yeast over mammalian cellular systems is the relatively straightforward way of performing genetic modifications.…”
Section: Discussionmentioning
confidence: 99%
“…Yeast cells are useful in the identification of genes important in drug toxicity (Bharucha & Kumar, 2007). An advantage of yeast over mammalian cellular systems is the relatively straightforward way of performing genetic modifications.…”
Section: Discussionmentioning
confidence: 99%
“…To identify the cellular targets of any bioactive compounds is a very difficult task. In the last years, however, all the genome resources that were developed for S. cerevisiae (www.yeastgenome.org) provided an excellent genomic platform for drug development and drug target identification (7,28,50,85). In addition, all these genetic tools have made it possible to study and construct genetic interaction networks for identification of specific drug targets (9,16).…”
mentioning
confidence: 99%
“…Enhancer studies identify a multiplied phenotype resulting from overexpression of a gene in a mutant strain. Genetic interaction networks, epistatic relationships and even drug targets [59] can be examined with overexpression strains. This section will discuss several collections that can be utilized to overexpress both essential and nonessential genes (Table 1).…”
Section: Gene Overexpression Libraries For Large-scale Analysismentioning
confidence: 99%